Navigation Links
Hepatitis C Virus Levels Higher in Certain Injection Drug Users
Date:7/13/2012

FRIDAY, July 13 (HealthDay News) -- Among injection-drug users in the United States infected with hepatitis C, virus levels are highest among blacks, males and those who are also infected with HIV, the virus that causes AIDS, a new study finds.

A 2010 report from the U.S. Centers for Disease Control and Prevention estimates that up to 3.9 million Americans have chronic hepatitis C infection, which is a leading cause of liver cancer, end-stage liver disease and liver transplantation.

The study was published in the July issue of the journal Hepatology.

Previous research indicates that one-third of injection-drug users aged 18 to 30 -- and up to 90 percent of older users -- are infected with the hepatitis C virus. With such high rates, it's important to learn more about the characteristics of infection in this group of people, Dr. Thomas O'Brien, of the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute, said in a journal news release.

O'Brien also noted that hepatitis C virus levels predict treatment response in people with chronic hepatitis C.

O'Brien and colleagues looked at approximately 1,700 black, Hispanic and white injection-drug users in San Francisco. Nearly 75 percent of the participants were men. Their average age was 46 and the average age at which they first used injection drugs was 18.

"We know that the level of [hepatitis C virus] is an important predictor of treatment response and that these levels seem to be influenced by a number of demographic, clinical, viral and human genetic factors," O'Brien concluded.

Hepatitis C virus causes long-term infection in up to 85 percent of people with the virus, according to the U.S. National Institute of Allergy and Infectious Diseases.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about hepatitis C.

-- Robert Preidt

SOURCE: Hepatology, news release, July 10, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Current and former smokers at risk for recurrent hepatitis post-liver transplantation
2. EASL-AASLD Special Conference on Therapy of Hepatitis C
3. Many Homeless May Harbor Hepatitis C
4. Hepatitis B Infection Rates in U.S. Higher Than Thought
5. 16th-century Korean mummy provides clue to hepatitis B virus genetic code
6. Hepatitis C Causing Liver Damage in Greater Numbers: Study
7. Test Baby Boomers for Hepatitis C, Says CDC
8. Gastroenterology special issue focuses on new directions of viral hepatitis care and research
9. Hepatitis C drug can cause depression
10. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
11. Moffitt researchers find cutaneous human papillomavirus infection a risk factor for skin cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hepatitis C Virus Levels Higher in Certain Injection Drug Users
(Date:4/29/2017)... LAKE CITY, UTAH (PRWEB) , ... April 29, 2017 , ... ... Northern California region. As a Phytomer Account Manager, Smith’s role is to ... skin care brands that make up The Phytomer Group. Smith comes to Phytomer with ...
(Date:4/29/2017)... ... April 29, 2017 , ... Saturday, April 29, marks World ... veterinarians have on animal health and welfare as well as on public health. ... choose a theme each year and this year have selected “Antimicrobial Resistance—From Awareness ...
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health ... Association of America (HCAOA). This agreement allows HCAOA members to receive special pricing ... discounts on Accreditation University (AU) educational resources that help prepare HCAOA members for ...
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals will be phasing ... the popular ClearLungs Extra Strength formula. To ensure that the effectiveness of Clear Lungs ... ways:, , Removal of the homeopathic element , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... , April 19, 2017 The Global ... Forecast to 2022 report has covered and analysed the potential ... information on market size, shares and growth factors. The report ... challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major ...
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
Breaking Medicine Technology: